CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation. [electronic resource]
Producer: 20071031Description: 603-7 p. digitalISSN:- 1743-4262
- Aged
- Antineoplastic Agents -- therapeutic use
- Brain Neoplasms -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Humans
- Lung Neoplasms -- genetics
- Male
- Mutation
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.